nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Gefitinib—lung cancer	0.0715	0.125	CbGbCtD
Hydrocodone—CYP2D6—Vinorelbine—lung cancer	0.0551	0.096	CbGbCtD
Hydrocodone—CYP3A4—Topotecan—lung cancer	0.0497	0.0867	CbGbCtD
Hydrocodone—CYP3A4—Gefitinib—lung cancer	0.0455	0.0793	CbGbCtD
Hydrocodone—CYP3A4—Teniposide—lung cancer	0.0441	0.0769	CbGbCtD
Hydrocodone—CYP2D6—Erlotinib—lung cancer	0.0423	0.0737	CbGbCtD
Hydrocodone—CYP3A4—Vinorelbine—lung cancer	0.035	0.0611	CbGbCtD
Hydrocodone—CYP2D6—Vinblastine—lung cancer	0.0339	0.0592	CbGbCtD
Hydrocodone—CYP3A4—Crizotinib—lung cancer	0.0279	0.0486	CbGbCtD
Hydrocodone—CYP3A4—Erlotinib—lung cancer	0.0269	0.0469	CbGbCtD
Hydrocodone—CYP3A4—Paclitaxel—lung cancer	0.0246	0.0429	CbGbCtD
Hydrocodone—CYP3A4—Irinotecan—lung cancer	0.0243	0.0423	CbGbCtD
Hydrocodone—CYP3A4—Vinblastine—lung cancer	0.0216	0.0376	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—lung cancer	0.0209	0.0364	CbGbCtD
Hydrocodone—CYP3A4—Etoposide—lung cancer	0.0194	0.0339	CbGbCtD
Hydrocodone—CYP3A4—Docetaxel—lung cancer	0.0178	0.031	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—lung cancer	0.0133	0.0231	CbGbCtD
Hydrocodone—Galantamine—CHRNA5—lung cancer	0.00324	0.236	CrCbGaD
Hydrocodone—Galantamine—CHRNB4—lung cancer	0.00219	0.16	CrCbGaD
Hydrocodone—Dextromethorphan—CHRNB4—lung cancer	0.00164	0.12	CrCbGaD
Hydrocodone—Galantamine—CHRNA3—lung cancer	0.00152	0.111	CrCbGaD
Hydrocodone—Naltrexone—UGT1A1—lung cancer	0.00148	0.108	CrCbGaD
Hydrocodone—Dextromethorphan—CHRNA3—lung cancer	0.00114	0.0829	CrCbGaD
Hydrocodone—Morphine—UGT1A1—lung cancer	0.000909	0.0663	CrCbGaD
Hydrocodone—Lethargy—Doxorubicin—lung cancer	0.000412	0.00133	CcSEcCtD
Hydrocodone—Rash—Topotecan—lung cancer	0.000411	0.00132	CcSEcCtD
Hydrocodone—Hypersensitivity—Vinorelbine—lung cancer	0.000411	0.00132	CcSEcCtD
Hydrocodone—Dermatitis—Topotecan—lung cancer	0.00041	0.00132	CcSEcCtD
Hydrocodone—Vomiting—Erlotinib—lung cancer	0.00041	0.00132	CcSEcCtD
Hydrocodone—Dyspnoea—Irinotecan—lung cancer	0.00041	0.00132	CcSEcCtD
Hydrocodone—Nervous system disorder—Cisplatin—lung cancer	0.000409	0.00132	CcSEcCtD
Hydrocodone—Cough—Etoposide—lung cancer	0.000409	0.00132	CcSEcCtD
Hydrocodone—Somnolence—Irinotecan—lung cancer	0.000409	0.00132	CcSEcCtD
Hydrocodone—Thrombocytopenia—Cisplatin—lung cancer	0.000409	0.00132	CcSEcCtD
Hydrocodone—Headache—Topotecan—lung cancer	0.000408	0.00131	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000408	0.00131	CcSEcCtD
Hydrocodone—Rash—Erlotinib—lung cancer	0.000407	0.00131	CcSEcCtD
Hydrocodone—Dermatitis—Erlotinib—lung cancer	0.000406	0.00131	CcSEcCtD
Hydrocodone—Convulsion—Etoposide—lung cancer	0.000406	0.00131	CcSEcCtD
Hydrocodone—Angiopathy—Docetaxel—lung cancer	0.000406	0.00131	CcSEcCtD
Hydrocodone—Skin disorder—Cisplatin—lung cancer	0.000405	0.00131	CcSEcCtD
Hydrocodone—Insomnia—Gemcitabine—lung cancer	0.000405	0.0013	CcSEcCtD
Hydrocodone—Headache—Erlotinib—lung cancer	0.000404	0.0013	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—lung cancer	0.000404	0.0013	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—lung cancer	0.000404	0.0013	CcSEcCtD
Hydrocodone—Hyperhidrosis—Cisplatin—lung cancer	0.000404	0.0013	CcSEcCtD
Hydrocodone—Mediastinal disorder—Docetaxel—lung cancer	0.000403	0.0013	CcSEcCtD
Hydrocodone—Paraesthesia—Gemcitabine—lung cancer	0.000402	0.00129	CcSEcCtD
Hydrocodone—Cough—Paclitaxel—lung cancer	0.000401	0.00129	CcSEcCtD
Hydrocodone—Asthenia—Vinorelbine—lung cancer	0.0004	0.00129	CcSEcCtD
Hydrocodone—Dyspnoea—Gemcitabine—lung cancer	0.000399	0.00129	CcSEcCtD
Hydrocodone—Nausea—Vinblastine—lung cancer	0.000398	0.00128	CcSEcCtD
Hydrocodone—Somnolence—Gemcitabine—lung cancer	0.000398	0.00128	CcSEcCtD
Hydrocodone—Convulsion—Paclitaxel—lung cancer	0.000398	0.00128	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—lung cancer	0.000397	0.00128	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—lung cancer	0.000397	0.00128	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000397	0.00128	CcSEcCtD
Hydrocodone—Fatigue—Irinotecan—lung cancer	0.000396	0.00128	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000396	0.00128	CcSEcCtD
Hydrocodone—Pruritus—Vinorelbine—lung cancer	0.000394	0.00127	CcSEcCtD
Hydrocodone—Constipation—Irinotecan—lung cancer	0.000393	0.00127	CcSEcCtD
Hydrocodone—Mental disorder—Docetaxel—lung cancer	0.000392	0.00126	CcSEcCtD
Hydrocodone—Myalgia—Paclitaxel—lung cancer	0.000391	0.00126	CcSEcCtD
Hydrocodone—Arthralgia—Paclitaxel—lung cancer	0.000391	0.00126	CcSEcCtD
Hydrocodone—Hypotension—Cisplatin—lung cancer	0.00039	0.00126	CcSEcCtD
Hydrocodone—Anxiety—Paclitaxel—lung cancer	0.00039	0.00126	CcSEcCtD
Hydrocodone—Malnutrition—Docetaxel—lung cancer	0.000389	0.00125	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000388	0.00125	CcSEcCtD
Hydrocodone—Nausea—Topotecan—lung cancer	0.000387	0.00125	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000387	0.00125	CcSEcCtD
Hydrocodone—Abdominal discomfort—Methotrexate—lung cancer	0.000386	0.00124	CcSEcCtD
Hydrocodone—Fatigue—Gemcitabine—lung cancer	0.000386	0.00124	CcSEcCtD
Hydrocodone—Constipation—Gemcitabine—lung cancer	0.000383	0.00123	CcSEcCtD
Hydrocodone—Nausea—Erlotinib—lung cancer	0.000383	0.00123	CcSEcCtD
Hydrocodone—Dry mouth—Paclitaxel—lung cancer	0.000383	0.00123	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—lung cancer	0.000382	0.00123	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00038	0.00122	CcSEcCtD
Hydrocodone—Back pain—Docetaxel—lung cancer	0.000377	0.00121	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Irinotecan—lung cancer	0.000376	0.00121	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—lung cancer	0.000375	0.00121	CcSEcCtD
Hydrocodone—Paraesthesia—Cisplatin—lung cancer	0.000375	0.00121	CcSEcCtD
Hydrocodone—Thrombocytopenia—Etoposide—lung cancer	0.000374	0.00121	CcSEcCtD
Hydrocodone—Muscle spasms—Docetaxel—lung cancer	0.000374	0.00121	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Methotrexate—lung cancer	0.000374	0.00121	CcSEcCtD
Hydrocodone—Dyspnoea—Cisplatin—lung cancer	0.000372	0.0012	CcSEcCtD
Hydrocodone—Skin disorder—Etoposide—lung cancer	0.000371	0.0012	CcSEcCtD
Hydrocodone—Hyperhidrosis—Etoposide—lung cancer	0.00037	0.00119	CcSEcCtD
Hydrocodone—Dizziness—Vinorelbine—lung cancer	0.000369	0.00119	CcSEcCtD
Hydrocodone—Nervous system disorder—Paclitaxel—lung cancer	0.000368	0.00118	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—lung cancer	0.000367	0.00118	CcSEcCtD
Hydrocodone—Thrombocytopenia—Paclitaxel—lung cancer	0.000367	0.00118	CcSEcCtD
Hydrocodone—Skin disorder—Paclitaxel—lung cancer	0.000364	0.00117	CcSEcCtD
Hydrocodone—Body temperature increased—Irinotecan—lung cancer	0.000363	0.00117	CcSEcCtD
Hydrocodone—Abdominal pain—Irinotecan—lung cancer	0.000363	0.00117	CcSEcCtD
Hydrocodone—Hyperhidrosis—Paclitaxel—lung cancer	0.000362	0.00117	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Cisplatin—lung cancer	0.00036	0.00116	CcSEcCtD
Hydrocodone—Drowsiness—Methotrexate—lung cancer	0.000359	0.00116	CcSEcCtD
Hydrocodone—Hypotension—Etoposide—lung cancer	0.000357	0.00115	CcSEcCtD
Hydrocodone—Vomiting—Vinorelbine—lung cancer	0.000354	0.00114	CcSEcCtD
Hydrocodone—Body temperature increased—Gemcitabine—lung cancer	0.000354	0.00114	CcSEcCtD
Hydrocodone—Rash—Vinorelbine—lung cancer	0.000351	0.00113	CcSEcCtD
Hydrocodone—Dermatitis—Vinorelbine—lung cancer	0.000351	0.00113	CcSEcCtD
Hydrocodone—Hypotension—Paclitaxel—lung cancer	0.00035	0.00113	CcSEcCtD
Hydrocodone—Headache—Vinorelbine—lung cancer	0.000349	0.00112	CcSEcCtD
Hydrocodone—Naltrexone—ABCB1—lung cancer	0.000345	0.0252	CrCbGaD
Hydrocodone—Paraesthesia—Etoposide—lung cancer	0.000343	0.00111	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000342	0.0011	CcSEcCtD
Hydrocodone—Dyspnoea—Etoposide—lung cancer	0.000341	0.0011	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP2E1—lung cancer	0.000341	0.0249	CrCbGaD
Hydrocodone—Somnolence—Etoposide—lung cancer	0.00034	0.00109	CcSEcCtD
Hydrocodone—Cough—Docetaxel—lung cancer	0.00034	0.00109	CcSEcCtD
Hydrocodone—Insomnia—Paclitaxel—lung cancer	0.000339	0.00109	CcSEcCtD
Hydrocodone—Hypersensitivity—Irinotecan—lung cancer	0.000339	0.00109	CcSEcCtD
Hydrocodone—Convulsion—Docetaxel—lung cancer	0.000337	0.00109	CcSEcCtD
Hydrocodone—Paraesthesia—Paclitaxel—lung cancer	0.000337	0.00108	CcSEcCtD
Hydrocodone—Agranulocytosis—Methotrexate—lung cancer	0.000335	0.00108	CcSEcCtD
Hydrocodone—Dyspnoea—Paclitaxel—lung cancer	0.000334	0.00108	CcSEcCtD
Hydrocodone—Somnolence—Paclitaxel—lung cancer	0.000333	0.00107	CcSEcCtD
Hydrocodone—Myalgia—Docetaxel—lung cancer	0.000332	0.00107	CcSEcCtD
Hydrocodone—Arthralgia—Docetaxel—lung cancer	0.000332	0.00107	CcSEcCtD
Hydrocodone—Nausea—Vinorelbine—lung cancer	0.000331	0.00107	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Etoposide—lung cancer	0.00033	0.00106	CcSEcCtD
Hydrocodone—Body temperature increased—Cisplatin—lung cancer	0.00033	0.00106	CcSEcCtD
Hydrocodone—Asthenia—Irinotecan—lung cancer	0.00033	0.00106	CcSEcCtD
Hydrocodone—Fatigue—Etoposide—lung cancer	0.00033	0.00106	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000329	0.00106	CcSEcCtD
Hydrocodone—Constipation—Etoposide—lung cancer	0.000327	0.00105	CcSEcCtD
Hydrocodone—Dry mouth—Docetaxel—lung cancer	0.000324	0.00104	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000324	0.00104	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000324	0.00104	CcSEcCtD
Hydrocodone—Fatigue—Paclitaxel—lung cancer	0.000323	0.00104	CcSEcCtD
Hydrocodone—Asthenia—Gemcitabine—lung cancer	0.000321	0.00103	CcSEcCtD
Hydrocodone—Constipation—Paclitaxel—lung cancer	0.000321	0.00103	CcSEcCtD
Hydrocodone—Pruritus—Gemcitabine—lung cancer	0.000317	0.00102	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Etoposide—lung cancer	0.000313	0.00101	CcSEcCtD
Hydrocodone—Nervous system disorder—Docetaxel—lung cancer	0.000312	0.001	CcSEcCtD
Hydrocodone—Thrombocytopenia—Docetaxel—lung cancer	0.000311	0.001	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—lung cancer	0.000311	0.001	CcSEcCtD
Hydrocodone—Skin disorder—Docetaxel—lung cancer	0.000309	0.000994	CcSEcCtD
Hydrocodone—Hypersensitivity—Cisplatin—lung cancer	0.000308	0.00099	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000307	0.000987	CcSEcCtD
Hydrocodone—Dizziness—Irinotecan—lung cancer	0.000304	0.000979	CcSEcCtD
Hydrocodone—Abdominal pain—Etoposide—lung cancer	0.000302	0.000973	CcSEcCtD
Hydrocodone—Body temperature increased—Etoposide—lung cancer	0.000302	0.000973	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—lung cancer	0.000302	0.000973	CcSEcCtD
Hydrocodone—Asthenia—Cisplatin—lung cancer	0.000299	0.000964	CcSEcCtD
Hydrocodone—Hypotension—Docetaxel—lung cancer	0.000297	0.000956	CcSEcCtD
Hydrocodone—Abdominal pain—Paclitaxel—lung cancer	0.000296	0.000954	CcSEcCtD
Hydrocodone—Body temperature increased—Paclitaxel—lung cancer	0.000296	0.000954	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—lung cancer	0.000293	0.000942	CcSEcCtD
Hydrocodone—Vomiting—Irinotecan—lung cancer	0.000292	0.000941	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—lung cancer	0.000291	0.000936	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—lung cancer	0.00029	0.000935	CcSEcCtD
Hydrocodone—Rash—Irinotecan—lung cancer	0.00029	0.000933	CcSEcCtD
Hydrocodone—Dermatitis—Irinotecan—lung cancer	0.00029	0.000933	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00029	0.000932	CcSEcCtD
Hydrocodone—Headache—Irinotecan—lung cancer	0.000288	0.000927	CcSEcCtD
Hydrocodone—Insomnia—Docetaxel—lung cancer	0.000287	0.000926	CcSEcCtD
Hydrocodone—Paraesthesia—Docetaxel—lung cancer	0.000285	0.000919	CcSEcCtD
Hydrocodone—Vomiting—Gemcitabine—lung cancer	0.000285	0.000917	CcSEcCtD
Hydrocodone—Dyspnoea—Docetaxel—lung cancer	0.000283	0.000912	CcSEcCtD
Hydrocodone—Somnolence—Docetaxel—lung cancer	0.000283	0.00091	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—lung cancer	0.000282	0.00091	CcSEcCtD
Hydrocodone—Rash—Gemcitabine—lung cancer	0.000282	0.000909	CcSEcCtD
Hydrocodone—Dermatitis—Gemcitabine—lung cancer	0.000282	0.000908	CcSEcCtD
Hydrocodone—Hypersensitivity—Etoposide—lung cancer	0.000282	0.000907	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—lung cancer	0.000281	0.000904	CcSEcCtD
Hydrocodone—Headache—Gemcitabine—lung cancer	0.000281	0.000903	CcSEcCtD
Hydrocodone—Hypersensitivity—Paclitaxel—lung cancer	0.000276	0.00089	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—lung cancer	0.000275	0.000886	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000274	0.000884	CcSEcCtD
Hydrocodone—Asthenia—Etoposide—lung cancer	0.000274	0.000884	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—lung cancer	0.000274	0.000883	CcSEcCtD
Hydrocodone—Fatigue—Docetaxel—lung cancer	0.000274	0.000882	CcSEcCtD
Hydrocodone—Nausea—Irinotecan—lung cancer	0.000273	0.000879	CcSEcCtD
Hydrocodone—Constipation—Docetaxel—lung cancer	0.000272	0.000875	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—lung cancer	0.000271	0.000874	CcSEcCtD
Hydrocodone—Pruritus—Etoposide—lung cancer	0.000271	0.000871	CcSEcCtD
Hydrocodone—Asthenia—Paclitaxel—lung cancer	0.000269	0.000866	CcSEcCtD
Hydrocodone—Nausea—Gemcitabine—lung cancer	0.000266	0.000857	CcSEcCtD
Hydrocodone—Vomiting—Cisplatin—lung cancer	0.000265	0.000855	CcSEcCtD
Hydrocodone—Pruritus—Paclitaxel—lung cancer	0.000265	0.000854	CcSEcCtD
Hydrocodone—Naloxone—ALB—lung cancer	0.000264	0.0193	CrCbGaD
Hydrocodone—Rash—Cisplatin—lung cancer	0.000263	0.000848	CcSEcCtD
Hydrocodone—Dermatitis—Cisplatin—lung cancer	0.000263	0.000847	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Docetaxel—lung cancer	0.00026	0.000837	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—lung cancer	0.000253	0.000816	CcSEcCtD
Hydrocodone—Dizziness—Etoposide—lung cancer	0.000253	0.000814	CcSEcCtD
Hydrocodone—Naloxone—ABCB1—lung cancer	0.000252	0.0184	CrCbGaD
Hydrocodone—Mediastinal disorder—Doxorubicin—lung cancer	0.000252	0.00081	CcSEcCtD
Hydrocodone—Abdominal pain—Docetaxel—lung cancer	0.000251	0.000809	CcSEcCtD
Hydrocodone—Body temperature increased—Docetaxel—lung cancer	0.000251	0.000809	CcSEcCtD
Hydrocodone—Dizziness—Paclitaxel—lung cancer	0.000248	0.000798	CcSEcCtD
Hydrocodone—Nausea—Cisplatin—lung cancer	0.000248	0.000798	CcSEcCtD
Hydrocodone—Cough—Methotrexate—lung cancer	0.000245	0.000789	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—lung cancer	0.000245	0.000788	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—lung cancer	0.000243	0.000783	CcSEcCtD
Hydrocodone—Vomiting—Etoposide—lung cancer	0.000243	0.000783	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—lung cancer	0.000243	0.000783	CcSEcCtD
Hydrocodone—Rash—Etoposide—lung cancer	0.000241	0.000776	CcSEcCtD
Hydrocodone—Dermatitis—Etoposide—lung cancer	0.000241	0.000776	CcSEcCtD
Hydrocodone—Headache—Etoposide—lung cancer	0.00024	0.000771	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—lung cancer	0.000239	0.000769	CcSEcCtD
Hydrocodone—Myalgia—Methotrexate—lung cancer	0.000239	0.000769	CcSEcCtD
Hydrocodone—Vomiting—Paclitaxel—lung cancer	0.000238	0.000768	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000237	0.000764	CcSEcCtD
Hydrocodone—Rash—Paclitaxel—lung cancer	0.000236	0.000761	CcSEcCtD
Hydrocodone—Dermatitis—Paclitaxel—lung cancer	0.000236	0.000761	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—lung cancer	0.000235	0.000757	CcSEcCtD
Hydrocodone—Headache—Paclitaxel—lung cancer	0.000235	0.000756	CcSEcCtD
Hydrocodone—Hypersensitivity—Docetaxel—lung cancer	0.000234	0.000754	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—lung cancer	0.000234	0.000752	CcSEcCtD
Hydrocodone—Asthenia—Docetaxel—lung cancer	0.000228	0.000734	CcSEcCtD
Hydrocodone—Nausea—Etoposide—lung cancer	0.000227	0.000731	CcSEcCtD
Hydrocodone—Pruritus—Docetaxel—lung cancer	0.000225	0.000724	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—lung cancer	0.000225	0.000723	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—lung cancer	0.000224	0.000722	CcSEcCtD
Hydrocodone—Nausea—Paclitaxel—lung cancer	0.000223	0.000717	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—lung cancer	0.000222	0.000716	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—lung cancer	0.000221	0.000713	CcSEcCtD
Hydrocodone—Hypotension—Methotrexate—lung cancer	0.000214	0.000689	CcSEcCtD
Hydrocodone—Morphine—ABCB1—lung cancer	0.000213	0.0155	CrCbGaD
Hydrocodone—Cough—Doxorubicin—lung cancer	0.000212	0.000683	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—lung cancer	0.000211	0.000678	CcSEcCtD
Hydrocodone—Dizziness—Docetaxel—lung cancer	0.00021	0.000677	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000209	0.000672	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—lung cancer	0.000207	0.000667	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—lung cancer	0.000207	0.000666	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—lung cancer	0.000207	0.000666	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—lung cancer	0.000206	0.000664	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—lung cancer	0.000206	0.000662	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000205	0.000662	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—lung cancer	0.000204	0.000658	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—lung cancer	0.000204	0.000656	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—lung cancer	0.000202	0.000652	CcSEcCtD
Hydrocodone—Vomiting—Docetaxel—lung cancer	0.000202	0.000651	CcSEcCtD
Hydrocodone—Rash—Docetaxel—lung cancer	0.0002	0.000645	CcSEcCtD
Hydrocodone—Dermatitis—Docetaxel—lung cancer	0.0002	0.000645	CcSEcCtD
Hydrocodone—Headache—Docetaxel—lung cancer	0.000199	0.000641	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000198	0.000637	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—lung cancer	0.000197	0.000636	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—lung cancer	0.000195	0.000626	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—lung cancer	0.000194	0.000625	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—lung cancer	0.000193	0.00062	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—lung cancer	0.000192	0.000617	CcSEcCtD
Hydrocodone—Nausea—Docetaxel—lung cancer	0.000189	0.000608	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methotrexate—lung cancer	0.000187	0.000603	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—lung cancer	0.000185	0.000597	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—lung cancer	0.000181	0.000583	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—lung cancer	0.000181	0.000583	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000181	0.000582	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—lung cancer	0.000179	0.000578	CcSEcCtD
Hydrocodone—Dextromethorphan—ABCB1—lung cancer	0.000179	0.013	CrCbGaD
Hydrocodone—Paraesthesia—Doxorubicin—lung cancer	0.000178	0.000574	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—lung cancer	0.000177	0.000569	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—lung cancer	0.000176	0.000568	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000171	0.000551	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—lung cancer	0.000171	0.000551	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—lung cancer	0.00017	0.000546	CcSEcCtD
Hydrocodone—Hypersensitivity—Methotrexate—lung cancer	0.000169	0.000543	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—lung cancer	0.000164	0.000529	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—lung cancer	0.000162	0.000522	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—lung cancer	0.000162	0.000522	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—lung cancer	0.000157	0.000505	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—lung cancer	0.000157	0.000505	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—lung cancer	0.000151	0.000488	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—lung cancer	0.000146	0.000471	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—lung cancer	0.000146	0.000469	CcSEcCtD
Hydrocodone—Rash—Methotrexate—lung cancer	0.000144	0.000465	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—lung cancer	0.000144	0.000465	CcSEcCtD
Hydrocodone—Headache—Methotrexate—lung cancer	0.000143	0.000462	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—lung cancer	0.000142	0.000458	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—lung cancer	0.00014	0.000452	CcSEcCtD
Hydrocodone—Nausea—Methotrexate—lung cancer	0.000136	0.000438	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—lung cancer	0.000131	0.000422	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—lung cancer	0.000126	0.000406	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—lung cancer	0.000125	0.000403	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—lung cancer	0.000125	0.000402	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—lung cancer	0.000124	0.0004	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—lung cancer	0.000118	0.000379	CcSEcCtD
Hydrocodone—CYP2D6—Metabolism—GSTA1—lung cancer	2.94e-05	0.000288	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCC3—lung cancer	2.91e-05	0.000285	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AVP—lung cancer	2.89e-05	0.000283	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	2.88e-05	0.000282	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL2—lung cancer	2.84e-05	0.000278	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TERT—lung cancer	2.83e-05	0.000277	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKR1C1—lung cancer	2.82e-05	0.000276	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1R—lung cancer	2.78e-05	0.000272	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM2—lung cancer	2.77e-05	0.000272	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CNDP2—lung cancer	2.77e-05	0.000272	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	2.77e-05	0.000271	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGFR1—lung cancer	2.75e-05	0.000269	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—UGT1A1—lung cancer	2.73e-05	0.000268	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HES1—lung cancer	2.73e-05	0.000268	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KIT—lung cancer	2.72e-05	0.000267	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APC—lung cancer	2.72e-05	0.000267	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CG—lung cancer	2.72e-05	0.000267	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—NRAS—lung cancer	2.72e-05	0.000266	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HIF1A—lung cancer	2.71e-05	0.000265	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTMR3—lung cancer	2.7e-05	0.000264	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGF—lung cancer	2.69e-05	0.000263	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—RAF1—lung cancer	2.68e-05	0.000262	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2—lung cancer	2.65e-05	0.000259	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GNG11—lung cancer	2.64e-05	0.000258	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PGAM1—lung cancer	2.63e-05	0.000257	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	2.62e-05	0.000256	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOA1—lung cancer	2.61e-05	0.000256	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MAPK3—lung cancer	2.61e-05	0.000255	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KDR—lung cancer	2.59e-05	0.000254	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—POMC—lung cancer	2.59e-05	0.000254	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—BRAF—lung cancer	2.56e-05	0.000251	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6R—lung cancer	2.53e-05	0.000247	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CREBBP—lung cancer	2.52e-05	0.000247	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—lung cancer	2.51e-05	0.000246	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDOA—lung cancer	2.51e-05	0.000246	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2A7—lung cancer	2.51e-05	0.000246	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB3—lung cancer	2.5e-05	0.000245	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—lung cancer	2.48e-05	0.000243	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SDC4—lung cancer	2.45e-05	0.00024	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOA3—lung cancer	2.44e-05	0.000239	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAP2K1—lung cancer	2.41e-05	0.000236	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2—lung cancer	2.4e-05	0.000235	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TERT—lung cancer	2.39e-05	0.000234	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CD—lung cancer	2.39e-05	0.000234	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CG—lung cancer	2.39e-05	0.000234	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KIT—lung cancer	2.39e-05	0.000234	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APC—lung cancer	2.39e-05	0.000234	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—NRAS—lung cancer	2.39e-05	0.000234	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADCY1—lung cancer	2.37e-05	0.000232	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCG2—lung cancer	2.37e-05	0.000232	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	2.37e-05	0.000232	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGF—lung cancer	2.36e-05	0.000231	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—KRAS—lung cancer	2.34e-05	0.000229	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ENO2—lung cancer	2.32e-05	0.000228	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HPGDS—lung cancer	2.32e-05	0.000228	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGFR1—lung cancer	2.32e-05	0.000228	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.31e-05	0.000226	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—lung cancer	2.29e-05	0.000224	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK3—lung cancer	2.29e-05	0.000224	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—POMC—lung cancer	2.27e-05	0.000222	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTT1—lung cancer	2.25e-05	0.000221	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BRAF—lung cancer	2.24e-05	0.00022	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—RRM1—lung cancer	2.24e-05	0.000219	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA3—lung cancer	2.24e-05	0.000219	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCLC—lung cancer	2.23e-05	0.000218	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2A6—lung cancer	2.23e-05	0.000218	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6R—lung cancer	2.22e-05	0.000217	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CREBBP—lung cancer	2.21e-05	0.000217	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOA1—lung cancer	2.21e-05	0.000216	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—lung cancer	2.19e-05	0.000214	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—lung cancer	2.17e-05	0.000213	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	2.15e-05	0.000211	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MDM2—lung cancer	2.14e-05	0.00021	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAF1—lung cancer	2.14e-05	0.000209	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ERBB2—lung cancer	2.11e-05	0.000207	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ENO1—lung cancer	2.11e-05	0.000207	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAP2K1—lung cancer	2.11e-05	0.000207	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—B4GALT5—lung cancer	2.1e-05	0.000206	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CD—lung cancer	2.1e-05	0.000205	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MTOR—lung cancer	2.08e-05	0.000204	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CB—lung cancer	2.08e-05	0.000204	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	2.08e-05	0.000203	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—KRAS—lung cancer	2.05e-05	0.000201	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA4—lung cancer	2.04e-05	0.0002	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KIT—lung cancer	2.02e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APC—lung cancer	2.02e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—lung cancer	2.02e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—NRAS—lung cancer	2.02e-05	0.000197	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—lung cancer	2e-05	0.000196	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGF—lung cancer	1.99e-05	0.000195	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA2—lung cancer	1.99e-05	0.000195	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HRAS—lung cancer	1.99e-05	0.000195	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—lung cancer	1.94e-05	0.00019	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK3—lung cancer	1.93e-05	0.000189	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA1—lung cancer	1.92e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—POMC—lung cancer	1.92e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—lung cancer	1.92e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—lung cancer	1.91e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—lung cancer	1.91e-05	0.000187	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCC3—lung cancer	1.9e-05	0.000186	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BRAF—lung cancer	1.9e-05	0.000186	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2E1—lung cancer	1.89e-05	0.000186	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	1.89e-05	0.000185	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MDM2—lung cancer	1.88e-05	0.000184	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NQO1—lung cancer	1.87e-05	0.000183	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAF1—lung cancer	1.87e-05	0.000183	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6R—lung cancer	1.87e-05	0.000183	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CREBBP—lung cancer	1.87e-05	0.000183	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—lung cancer	1.87e-05	0.000183	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JUN—lung cancer	1.86e-05	0.000182	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ERBB2—lung cancer	1.85e-05	0.000181	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKR1C1—lung cancer	1.84e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—lung cancer	1.84e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CB—lung cancer	1.83e-05	0.000179	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MTOR—lung cancer	1.83e-05	0.000179	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—lung cancer	1.81e-05	0.000177	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1A—lung cancer	1.81e-05	0.000177	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTEN—lung cancer	1.8e-05	0.000176	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—UGT1A1—lung cancer	1.79e-05	0.000175	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAP2K1—lung cancer	1.78e-05	0.000175	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CD—lung cancer	1.77e-05	0.000174	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—lung cancer	1.76e-05	0.000172	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—lung cancer	1.76e-05	0.000172	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.76e-05	0.000172	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HRAS—lung cancer	1.75e-05	0.000171	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—KRAS—lung cancer	1.74e-05	0.00017	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GNG11—lung cancer	1.72e-05	0.000169	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EP300—lung cancer	1.72e-05	0.000168	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—lung cancer	1.7e-05	0.000166	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—STK11—lung cancer	1.69e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—lung cancer	1.68e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—lung cancer	1.68e-05	0.000164	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SRC—lung cancer	1.67e-05	0.000164	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—lung cancer	1.67e-05	0.000164	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDOA—lung cancer	1.64e-05	0.000161	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—lung cancer	1.64e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JUN—lung cancer	1.63e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—lung cancer	1.63e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—lung cancer	1.61e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NRAS—lung cancer	1.61e-05	0.000157	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	1.59e-05	0.000156	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA3—lung cancer	1.59e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—lung cancer	1.59e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MDM2—lung cancer	1.59e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1A—lung cancer	1.58e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAF1—lung cancer	1.58e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTEN—lung cancer	1.58e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB2—lung cancer	1.57e-05	0.000153	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—lung cancer	1.56e-05	0.000153	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADCY1—lung cancer	1.55e-05	0.000152	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG2—lung cancer	1.55e-05	0.000152	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CB—lung cancer	1.55e-05	0.000151	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MTOR—lung cancer	1.55e-05	0.000151	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—lung cancer	1.54e-05	0.000151	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK3—lung cancer	1.54e-05	0.000151	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CAT—lung cancer	1.52e-05	0.000149	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HPGDS—lung cancer	1.52e-05	0.000149	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ENO2—lung cancer	1.52e-05	0.000149	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.51e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EP300—lung cancer	1.51e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—lung cancer	1.5e-05	0.000147	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—lung cancer	1.48e-05	0.000145	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCB1—lung cancer	1.48e-05	0.000145	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HRAS—lung cancer	1.48e-05	0.000144	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTT1—lung cancer	1.47e-05	0.000144	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SRC—lung cancer	1.47e-05	0.000143	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—lung cancer	1.46e-05	0.000143	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2A6—lung cancer	1.46e-05	0.000143	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCLC—lung cancer	1.46e-05	0.000143	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TYMS—lung cancer	1.45e-05	0.000142	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—lung cancer	1.44e-05	0.000141	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—lung cancer	1.43e-05	0.00014	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—lung cancer	1.43e-05	0.00014	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—lung cancer	1.42e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—lung cancer	1.42e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—lung cancer	1.41e-05	0.000138	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—lung cancer	1.41e-05	0.000138	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NRAS—lung cancer	1.41e-05	0.000138	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KRAS—lung cancer	1.38e-05	0.000135	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—lung cancer	1.38e-05	0.000135	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ENO1—lung cancer	1.38e-05	0.000135	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JUN—lung cancer	1.38e-05	0.000135	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A1—lung cancer	1.36e-05	0.000133	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ERCC2—lung cancer	1.35e-05	0.000132	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK3—lung cancer	1.35e-05	0.000132	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—lung cancer	1.34e-05	0.000132	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1A—lung cancer	1.34e-05	0.000131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTEN—lung cancer	1.34e-05	0.000131	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—lung cancer	1.31e-05	0.000129	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—lung cancer	1.3e-05	0.000128	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—lung cancer	1.28e-05	0.000126	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EP300—lung cancer	1.27e-05	0.000125	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—lung cancer	1.27e-05	0.000124	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2E1—lung cancer	1.24e-05	0.000121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SRC—lung cancer	1.24e-05	0.000121	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—lung cancer	1.23e-05	0.00012	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NQO1—lung cancer	1.22e-05	0.00012	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KRAS—lung cancer	1.21e-05	0.000119	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—lung cancer	1.21e-05	0.000118	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—lung cancer	1.19e-05	0.000117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NRAS—lung cancer	1.19e-05	0.000117	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HRAS—lung cancer	1.18e-05	0.000115	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA1—lung cancer	1.17e-05	0.000114	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.14e-05	0.000112	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—lung cancer	1.13e-05	0.00011	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.11e-05	0.000109	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—lung cancer	1.11e-05	0.000109	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—STK11—lung cancer	1.1e-05	0.000108	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—lung cancer	1.09e-05	0.000106	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—lung cancer	1.08e-05	0.000106	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—lung cancer	1.07e-05	0.000104	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—lung cancer	1.04e-05	0.000102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HRAS—lung cancer	1.03e-05	0.000101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KRAS—lung cancer	1.03e-05	0.0001	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—lung cancer	1.02e-05	0.0001	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—POMC—lung cancer	1.01e-05	9.94e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CAT—lung cancer	9.94e-06	9.74e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CREBBP—lung cancer	9.88e-06	9.68e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—lung cancer	9.87e-06	9.67e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCB1—lung cancer	9.67e-06	9.47e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TYMS—lung cancer	9.5e-06	9.3e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—lung cancer	9.42e-06	9.23e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—lung cancer	9.39e-06	9.19e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CD—lung cancer	9.37e-06	9.18e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—lung cancer	9.25e-06	9.06e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—lung cancer	9.11e-06	8.92e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—lung cancer	9.1e-06	8.92e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A1—lung cancer	8.9e-06	8.72e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ERCC2—lung cancer	8.83e-06	8.64e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HRAS—lung cancer	8.71e-06	8.54e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—lung cancer	8.34e-06	8.17e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CB—lung cancer	8.17e-06	8e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—lung cancer	8.09e-06	7.93e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—lung cancer	7.69e-06	7.54e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA1—lung cancer	7.63e-06	7.48e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTEN—lung cancer	7.06e-06	6.91e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—lung cancer	6.97e-06	6.83e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—EP300—lung cancer	6.73e-06	6.59e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—POMC—lung cancer	6.63e-06	6.5e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CREBBP—lung cancer	6.46e-06	6.33e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CD—lung cancer	6.13e-06	6e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—lung cancer	6.05e-06	5.92e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CB—lung cancer	5.34e-06	5.23e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—lung cancer	5.29e-06	5.18e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—lung cancer	4.98e-06	4.88e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTEN—lung cancer	4.62e-06	4.52e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—EP300—lung cancer	4.4e-06	4.31e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—lung cancer	4.07e-06	3.98e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—lung cancer	3.26e-06	3.19e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—lung cancer	2.66e-06	2.61e-05	CbGpPWpGaD
